Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Inventory (2019 - 2025)

Historic Change in Inventory for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $1.0 million.

  • Pulmonx's Change in Inventory rose 27130.87% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108000.0, marking a year-over-year increase of 10848.39%. This contributed to the annual value of $229000.0 for FY2024, which is 12494.55% up from last year.
  • Per Pulmonx's latest filing, its Change in Inventory stood at $1.0 million for Q3 2025, which was up 27130.87% from -$660000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Change in Inventory ranged from a high of $2.0 million in Q1 2022 and a low of -$1.3 million during Q4 2023
  • Over the past 5 years, Pulmonx's median Change in Inventory value was $604000.0 (recorded in 2023), while the average stood at $492736.8.
  • Its Change in Inventory has fluctuated over the past 5 years, first tumbled by 46341.46% in 2024, then soared by 27130.87% in 2025.
  • Over the past 5 years, Pulmonx's Change in Inventory (Quarter) stood at $1.5 million in 2021, then crashed by 136.91% to -$536000.0 in 2022, then crashed by 151.68% to -$1.3 million in 2023, then soared by 111.34% to $153000.0 in 2024, then soared by 567.32% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, -$660000.0 for Q2 2025, and -$406000.0 during Q1 2025.